ARTICLE | Company News
Two more alliances for Elan
February 15, 2000 8:00 AM UTC
Athersys (Cleveland, Ohio) and ELN formed a joint venture to develop a protein to treat AIDS-related muscle wasting. The venture will combine Athersys' Random Activation of Gene Expression (RAGE) technology with ELN's Medipad drug delivery system. ELN made an equity investment in Athersys. ...